Attending ASTRO 2020 Virtual Meeting?

We’ve taken the opportunity to highlight some content focused on Particle Therapy. We wish you all a successful meeting


  • International Session 04 - IAEA - ASTRO Joint Session: Promises and Pitfalls of Proton Beam Therapy for New Adopters of Advanced Technology ― Global Perspectives
  • SS 06 - CNS 01 - Gliomas (Low Grade, High Grade), BN001 Preliminary Results, On Demand Sat 24th 12AM
  • SS 30 - H&N 02 - Practical Head & Neck Radiotherapy, Talk: 179 Development of Advanced Preselection Tools to Reduce Unnecessary Plan Comparisons in Model-Based Selection of Head and Neck Cancer Patients for Proton Therapy
  • EDU 17 - Lung Cancer Difficult Cases: Thoracic Re-Treatment,Talk: Protons for Recurrence,  Monday, Oct 26 11:00 AM
  • Panel 05 - Mechanisms and Clinical Translation of FLASH-RT, , On Demand Monday, Oct 26 12:00 AM

Scientific Session Abstract Numbers:

  • 59 Pericardial Effusion and Mortality in Patients Treated with Photons and Protons for Locally Advanced Non-Small-Cell Lung Cancer: The Voxel-Based Perspective
  • 72 Proton Therapy for Pediatric Ependymoma: Mature Results from a Multi-Center Study
  • 74 Proton Radiation Therapy for Pediatric Chordomas of the Base of Skull.
  • 75 Vasculopathy in Pediatric Craniopharyngioma Patients Treated with Surgery and Proton Radiotherapy
  • 76 Health Outcomes and Quality of Life in a Multi-institutional Prospective Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma
  • 77 Incorporation of Limited Margin, Dose Escalated Proton Beam RT to 59.4Gy(RBE) in Children with Rhabdomyosarcoma
  • 84 The feasibility and accuracy of utilizing CBCT and Generative-Adversarial-Network (GAN) to perform proton treatment dose evaluation for Lung and Head&Neck patients
  • 92 Comparing Healthcare Utilization, Hospitalization, and Costs with Neoadjuvant Intensity-Modulated Radiation Therapy (IMRT) versus Proton Beam Therapy (PBT) for Esophageal Cancer
  • 137 FLASH Proton Irradiation using a Synchrocyclotron: Proof of Concept
  • 158 4D dose reconstruction and accumulation brings confidence into proton treatments of moving tumors
  • 159 Evaluation of Proton Dose Accuracy Improvements with Dual-Energy CT
  • 160 Anatomic Changes in Head and Neck Intensity-Modulated Proton Therapy: Comparison between Robust Optimization and Daily Adaptation

Quick Pitch Abstracts:

  • 1018 Clinically Significant Toxicities Attributable to Pencil Beam Scanning Proton Therapy in Pediatric Patients Enrolled in a Single Institution Phase IV Clinical Trial: Early Results from SJPROTON1 
  • 1021 Long Term Clinical Outcomes of Proton Radiotherapy for Pediatric Medulloblastoma
  • 1022 Second Tumors in Pediatric Patients Treated with Double-Scattered Proton Therapy
  • 1023 Atypical Resting State Functional Connectivity and Deficits in Cognition in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation
  • 1041 Race Disparities in High-cost, Limited Resource Cancer Treatment: Proton Radiotherapy Use in Patients Enrolled on Children’s Oncology Group Trials
  • 1046 Cardiac Events Following Radiotherapy for Locally Advanced Non-Small Cell Lung Carcinoma: A Comparison between Photon and Proton Beam Radiotherapy
  • 1049 Selection of Mediastinal Lymphoma Patients for Proton Therapy in a Prospective Multi-Institutional Registry: Concordance with the ILROG Guidelines
  • 1050 An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most?
  • 1056 Public List Prices for Self-pay Proton Radiotherapy
  • 1057 Establishing Mean Heart Dose Thresholds for Cost-effective Allocation of Proton Regional Nodal Irradiation
  • 1087 Differences in Lymphocyte Count after Abdominal Flash or Conventional Proton Irradiation
  • 1093 Comparison of Prospective, Longitudinal Swallowing Function After Primary Intensity-Modulated Proton Therapy (IMPT) or Transoral Robotic Surgery (TORS) for Oropharyngeal Squamous Cell Carcinoma
  • 1096 A Prospective Study of Mucosal Sparing Proton Beam Therapy in Resected Oropharyngeal Cancer Patients: Toxicity, Quality of Life and Swallow Function
  • 1115 Online Prediction of Dosimetric Changes in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
  • 1131 Adaptive Proton Therapy for Pediatric Patients: Improving Delivered Plan Quality with On-treatment MRI
  • 1134 Proton Radiotherapy for Infant Rhabdomyosarcoma: Rethinking Young Age as an Adverse Prognostic Factor
  • 1149 Conventionally Fractionated FLASH Treatment Planning for Head and Neck Cancer using Transmission Beam Proton Therapy


October 24, 2020
Attending the ASTRO 2020 Annual Meeting? Check Out Particle Therapy Content HERE.
September 23, 2020
Save the Date for PTCOG´s next event.
October 30, 2019
Visit our New Membership Portal to become a PTCOG-NA member.


PTCOG-NA Secretariat


Subscribe for PTCOG-NA Updates

PTCOG-NA Copyright © 2019. All Rights Reserved.
Powered by APPTIDE | Terms of Service